BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Adalimumab

Presentation	Product	Chemical substance	Chapter	Items dispensed
Adalimumab 40mg/0.4ml inj pre-filled disposable devices 1001030S0AAADAD	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	4
Adalimumab 40mg/0.8ml inj pre-filled disposable devices 1001030S0AAABAB	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	2
Adalimumab 40mg/0.4ml inj pre-filled syringes 1001030S0AAAEAE	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	1
Adalimumab 20mg/0.2ml inj pre-filled syringes 1001030S0AAAFAF	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Adalimumab 20mg/0.4ml inj pre-filled syringes 1001030S0AAAIAI	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Adalimumab 40mg/0.8ml inj pre-filled syringes 1001030S0AAAAAA	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Adalimumab 40mg/0.8ml solution for injection vials 1001030S0AAACAC	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Adalimumab 80mg/0.8ml inj pre-filled disposable devices 1001030S0AAAHAH	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Adalimumab 80mg/0.8ml inj pre-filled syringes 1001030S0AAAGAG	Adalimumab	Adalimumab	Musculoskeletal and Joint Diseases	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.